Strata Critical Medical, Inc. (SRTA) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net buyers over the last 90 days ($10.0K bought vs $0 sold). Latest close $4.96 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 5, 2026 · Congress to Nov 16, 2026.
Third Point · First Eagle Investment Management — 2 tracked funds hold SRTA. See all holders.
Insiders bought on the open market (1 purchase, $10.0K) vs 0 sales ($0). Latest buy: Nov 5, 2026. Insider trading
LifeStance Health Group, Inc. (LFST) · Pennant Group, Inc. (PNTG) · Privia Health Group, Inc. (PRVA) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Third Point | 0.56% | 5,000,000 | HELD Q3 filed Nov 16 |
| First Eagle Investment Management | 0.02% | 2,314,614 | ADDED (+2.1%) Q3 filed Nov 10 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -0.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 140 of 8,857 filers |
| Long-only filers among them | 139 |
| Change vs 2026 Q1 | +18 net · 137 entered · 119 exited |
| Shares reported, all filers | 53,418,097 |
| Reported value, all filers | $283.1M |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | Nasdaq |
| Industry | Services-Health Services (SIC 8000) |
| Revenue · FY2025 | $197.1M |
| Net income · FY2025 | $41.3M |
| Total assets · FY2025 | $325.5M |
| Shares outstanding | 88,466,806 |
| Market cap (at latest close) | $438.8M |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 28, 2026.
| Shares short · Oct 15, 2026 | 4,538,023 |
| Share of shares outstanding | 5.13% |
| Days to cover | 5.00 |
Shares short at recent settlements — Jul 31, 2026: 4.2M · Aug 14, 2026: 4.2M · Aug 31, 2026: 4.5M · Sep 15, 2026: 4.4M · Sep 30, 2026: 4.3M · Oct 15, 2026: 4.5M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 28, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 28, 2026.
1 insider bought on the open market in the last 90 days (1 purchase, $10.0K), against 0 sales by 0 insiders ($0). Latest buy: Nov 5, 2026.
Source: SEC Form 4 filings. Open-market transactions only.
| Latest open-market buy | Transaction price | Price change since disclosure |
|---|---|---|
| LAUCK ANDREW · 2,000 shares on Nov 5, 2026 · filed Nov 9, 2026 | $5.00 | -13.0% (close Nov 10, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Nov 10, 2026). The transaction price is what the insider paid; the price change is on closing prices (dividends excluded).
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | LAUCK ANDREW | Buy | 2,000 | $5.00 | $10.0K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | The Eric L. Affeldt Living Trust DTD 2/14/2005 | Former Boardmember | 100,000 | $517.0K | Oct 2, 2026 | SEC filing |
| May 11, 2026 | AMIR COHEN | Officer | 65,181 | $363.1K | May 11, 2026 | SEC filing |
| Nov 20, 2025 | Reginald Lamonte Love | Director | 11,000 | $48.1K | Nov 20, 2025 | SEC filing |
| Nov 19, 2025 | Reginald Lamonte Love | Director | 11,000 | $47.4K | Nov 19, 2025 | SEC filing |
| Aug 4, 2025 | MELISSA TOMKIEL | Officer | 47,995 | $181.4K | Aug 4, 2025 | SEC filing |
| Aug 4, 2025 | WILLIAM A HEYBURN | Officer | 46,918 | $177.4K | Aug 4, 2025 | SEC filing |
| Jun 9, 2025 | WILLIAM A HEYBURN | Officer | 100,000 | $380.0K | Jun 9, 2025 | SEC filing |
| Jun 9, 2025 | MELISSA TOMKIEL | Officer | 100,000 | $380.0K | Jun 9, 2025 | SEC filing |
| Dec 13, 2024 | Borthwick John | Director | 78,291 | $297.5K | Dec 13, 2024 | SEC filing |
| Dec 13, 2024 | Love Reginald | Director | 5,091 | $20.6K | Dec 13, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| May 8, 2026 | SCHEDULE 13D/A | -7.4% (close May 11, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (May 11, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Steele ExpCo Holdings, LLC | SC 13G/A | 7,923,000 | 9.0% | Jun 30, 2026 | SEC filing |
| Jul 8, 2026 | ARK Investment Management LLC | SC 13G/A | 2,730,855 | 3.2% | Jun 30, 2026 | SEC filing |
| Jun 17, 2026 | Northern Right Capital Management, L.P. | SC 13G | 4,398,235 | 5.1% | Jun 11, 2026 | SEC filing |
| May 8, 2026 | Krstic Velibor | SC 13D/A | 0 | 0.0% | May 7, 2026 | SEC filing |
| Apr 30, 2026 | ARK Investment Management LLC | SC 13G/A | 7,455,284 | 8.6% | Mar 31, 2026 | SEC filing |
| Apr 16, 2026 | Krstic Velibor | SC 13D/A | 1,485,877 | 16.2% | Apr 15, 2026 | SEC filing |
| Apr 8, 2026 | Krstic Velibor | SC 13D/A | 1,139,393 | 12.4% | Apr 8, 2026 | SEC filing |
| Apr 7, 2026 | Krstic Velibor | SC 13D | 764,435 | 8.3% | Apr 1, 2026 | SEC filing |
| Jan 21, 2026 | BlackRock, Inc. | SC 13G | 4,384,945 | 5.1% | Dec 31, 2025 | SEC filing |
| Nov 14, 2025 | Third Point LLC | SC 13G/A | 5,000,000 | 5.8% | Sep 30, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: Services-Health Services (SIC 8000). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Insiders
· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions
Financial Screens
· Deep Value (Templeton) — Stocks that are cheap against both earnings and assets
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Red Flags
· Earnings Manipulation Suspect (Beneish) — Beneish M-Score above -1.78
Key figures
· Deep Value (Templeton) — P/E: 9.50 · P/B: 1.40 · Latest EPS: 0.50 · Dividend yield: 0.0%
· Insider Net Buying — Buy txns: 1 · Sell txns: 0 · Buy value: $10.0K · Latest buy: Nov 5, 2026
· Earnings Manipulation Suspect (Beneish) — M-Score: -0.07 · Receivables index: 1.50 · Margin deterioration: 0.97 · Sales growth index: 1.34 · Accruals ratio: 27.7%
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
Also held by the tracked funds that hold SRTA — ranked by lift, the co-holding pattern described in Methodology: LifeStance Health Group, Inc. (LFST) · Pennant Group, Inc. (PNTG) · Privia Health Group, Inc. (PRVA) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) · Acadia Healthcare Company, Inc. (ACHC).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Nov 3, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Aug 4, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Jun 3, 2026 | 5.07 Submission of Matters to a Vote of Security Holders | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
LifeStance Health Group, Inc. (LFST) · Track Record: how the signals scored · Practice timing on SRTA
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.